We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

Search results

From Proteopedia

You searched for Sirt

Jump to: navigation, search

There is no page with the exact title "Sirt". The search results for "Sirt" are displayed below. You can create a page titled Sirt (by clicking on the red link).

For more information about searching Proteopedia, see Help.

To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.

Showing below up to 20 results starting with #1.


View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)

Article title matches

  1. Category:Sirt (35 bytes)
    1: List of pages with the keyword Sirt

Page text matches

  1. 4i5i (15,193 bytes)
    2: ==Crystal structure of the SIRT1 catalytic domain bound to NAD and an EX527 analo...
    11: ... SirtT1 75 kDa fragment: catalytically inactive 75SirT1 may be involved in regulation of apoptosis. May ...
    14: ...mation sterically prevents substrate binding. The SIRT1/NAD(+)/35 crystal structure defines a novel mech...
    16: The 2.5 A crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine d...
  2. Histone deacetylase (2,330 bytes)
    1: ...on load='' size='350' side='right' caption='Human sirtuin-3 complex with peptide containing acetylated l...
    7: ...d '''sirtuin''' - (Silent Information Regulator) (SIRT) are NAD-dependent HDAC. This protein is bifuncti...
    17: ... used in cancer therapy<ref>PMID:11902574</ref>. Sirtuins play a role in cancer, metabolic activity and...
    20: ...ded conformation</scene> between the 2 domains of SIRT3 - a large Rossman fold, NAD-binding domain and a...
  3. Category:Sirt (35 bytes)
    1: List of pages with the keyword Sirt
  4. 5y2f (5,180 bytes)
    2: ==Human SIRT6 in complex with allosteric activator MDL-801==
    14: ...cally and pathologically investigate the roles of SIRT6 deacetylation.
    16: Identification of a cellularly active SIRT6 allosteric activator.,Huang Z, Zhao J, Deng W, C...
  5. 5y4h (3,549 bytes)
    2: ==Human SIRT3 in complex with halistanol sulfate==
    14: ... clearly indicates that 1 binds to the exosite of SIRT3 that we have discovered in this study.
    16: Halistanol sulfates I and J, new SIRT1-3 inhibitory steroid sulfates from a marine spon...
  6. 6b0u (3,326 bytes)
    14: ...cetylation of HupB by Eis. We also found that the SirT-family NAD(+)-dependent deacetylase Rv1151c from ...
  7. Human MnSOD and Cancer Research (9,142 bytes)
    19: ...ated in regard to the activation and knockdown of SIRT3. From this, they were able to determine a way to...
  8. 6ljk (4,911 bytes)
    2: ==Crystal structure of human Sirt5 in complex with an internally quenched fluoresce...
    14: ...ing new substrates and inhibitors targeting human SIRTs.
    16: Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery.,Yang LL, Wang H...
  9. 6ljm (4,851 bytes)
    2: ==Crystal structure of human Sirt5 in complex with the fluorogenic tetrapeptide sub...
    14: ...ing new substrates and inhibitors targeting human SIRTs.
    16: Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery.,Yang LL, Wang H...
  10. 6ljn (4,850 bytes)
    2: ==Crystal structure of human Sirt5 in complex with the fluorogenic tetrapeptide sub...
    14: ...ing new substrates and inhibitors targeting human SIRTs.
    16: Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery.,Yang LL, Wang H...
  11. 7vke (6,458 bytes)
    14: ...atography; SEM: standard error of the mean; SIRT: sirtuins; SPR: surface plasmon resonance; microg: micr...
  12. 9s1z (4,751 bytes)
    2: ==Crystal structure of human SIRT2 in complex with the covalent adduct of SirReal-t...
    14: ...t engagement confirmed by NanoBRET assays. Beyond SIRTs, this inhibition strategy may extend to other NA...
    16: ...ad: NAD(+)-Targeting Triazoles as Mechanism-Based Sirtuin Inhibitors.,Friedrich F, Meleshin M, Papenkord...
  13. 9s20 (4,569 bytes)
    2: ==Crystal structure of human SIRT2 in complex with SirReal-triazole inhibitor SH10=...
    14: ...t engagement confirmed by NanoBRET assays. Beyond SIRTs, this inhibition strategy may extend to other NA...
    16: ...ad: NAD(+)-Targeting Triazoles as Mechanism-Based Sirtuin Inhibitors.,Friedrich F, Meleshin M, Papenkord...
  14. 9s21 (4,499 bytes)
    2: ==Crystal structure of human SIRT2 in complex with SirReal-triazole inhibitor LG023...
    14: ...t engagement confirmed by NanoBRET assays. Beyond SIRTs, this inhibition strategy may extend to other NA...
    16: ...ad: NAD(+)-Targeting Triazoles as Mechanism-Based Sirtuin Inhibitors.,Friedrich F, Meleshin M, Papenkord...
  15. 9s22 (4,665 bytes)
    2: ==Crystal structure of human SIRT2 in complex with the covalent adduct of SirReal-t...
    14: ...t engagement confirmed by NanoBRET assays. Beyond SIRTs, this inhibition strategy may extend to other NA...
    16: ...ad: NAD(+)-Targeting Triazoles as Mechanism-Based Sirtuin Inhibitors.,Friedrich F, Meleshin M, Papenkord...
  16. 9s23 (4,426 bytes)
    2: ==Crystal structure of human SIRT2 in complex with peptide triazole inhibitor OTDi1...
    14: ...t engagement confirmed by NanoBRET assays. Beyond SIRTs, this inhibition strategy may extend to other NA...
    16: ...ad: NAD(+)-Targeting Triazoles as Mechanism-Based Sirtuin Inhibitors.,Friedrich F, Meleshin M, Papenkord...
  17. 9s24 (4,630 bytes)
    2: ==Crystal structure of human SIRT2 in complex with the covalent adduct of peptide t...
    14: ...t engagement confirmed by NanoBRET assays. Beyond SIRTs, this inhibition strategy may extend to other NA...
    16: ...ad: NAD(+)-Targeting Triazoles as Mechanism-Based Sirtuin Inhibitors.,Friedrich F, Meleshin M, Papenkord...
  18. 9s25 (4,371 bytes)
    2: ==Crystal structure of human SIRT2 in complex with peptide triazole inhibitor LTDi1...
    14: ...t engagement confirmed by NanoBRET assays. Beyond SIRTs, this inhibition strategy may extend to other NA...
    16: ...ad: NAD(+)-Targeting Triazoles as Mechanism-Based Sirtuin Inhibitors.,Friedrich F, Meleshin M, Papenkord...
  19. 9s26 (4,613 bytes)
    2: ==Crystal structure of human SIRT2 in complex with the covalent adduct of peptide t...
    14: ...t engagement confirmed by NanoBRET assays. Beyond SIRTs, this inhibition strategy may extend to other NA...
    16: ...ad: NAD(+)-Targeting Triazoles as Mechanism-Based Sirtuin Inhibitors.,Friedrich F, Meleshin M, Papenkord...
  20. 9s27 (4,588 bytes)
    2: ==Crystal structure of human SIRT3 in complex with the covalent adduct of peptide t...
    14: ...t engagement confirmed by NanoBRET assays. Beyond SIRTs, this inhibition strategy may extend to other NA...
    16: ...ad: NAD(+)-Targeting Triazoles as Mechanism-Based Sirtuin Inhibitors.,Friedrich F, Meleshin M, Papenkord...

View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)



Search in namespaces:

Include only Seeded (Automatic) pages - only Human created pages
List redirects
Search for

You may also try
Views
Personal tools